Production & Manufacturing

Matica Biotechnology, Inc., which happens to be a leading contract development and manufacturing organization (CDMO) that specializes in viral vector manufacturing in terms of cell and gene therapies, announced on September 15, a strategic commercial manufacturing deal along with...

Partnership delivers global, end-to-end solutions to accelerate genomics research Sapio Sciences, the science-awareTM lab informatics platform, today announced a strategic partnership with Ultima Genomics. The collaboration will make multi-omics workflows more accessible and streamlined for researchers by integrating Sapio’s AI-powered lab informatics...

It is worth noting that the pharmaceutical sector’s recent source of novel molecules may as well be coming under threat. Apparently, it is the White House which is reportedly preparing an executive order that is going to place restrictions...

Maintaining Track-and-Trace Integrity in Extreme Temperature Environments The pharmaceutical industry's increasing reliance on cryogenic storage and transportation for advanced therapies, including cell and gene treatments, vaccines, and specialized biologics, presents unique challenges for maintaining the integrity of serialization systems, RFID...

Transforming Pharmaceutical Cold Chain Through Connected Intelligence The pharmaceutical industry has witnessed a revolutionary transformation in cold chain management through the implementation of Internet of Things (IoT) sensors, which provide unprecedented visibility and control over temperature-sensitive products such as vaccines...

LOTTE BIOLOGICS, on September 1, 2025, announced that it has gone on to enter into a late-stage commercial contract manufacturing collaboration along with one of the global biopharmaceutical companies from the US. It is well to be noted that this...

Johnson & Johnson on August 21, 2025, went on to announce that it will be adding another 160,000 ft.² dedicated manufacturing facility in its Fujifilm site based at Holly Springs, NC. This is going to be a part of...